That is necessary, since the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're created to do. This was a breakthrough almost no one discovered. But it's going to have profound implications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of investment opportunities in this space, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back perhaps substantially prior to going higher. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. jeff brown genetic sequencer stock. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly educating readers. However that's not the huge concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that (genetic sequencer stock jeff brown). In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43% (united arab emirates). I predict 2021 will be another record year in IPOs. There are numerous fantastic personal business on the edge of hitting the public markets And I have actually been working on a brand-new way for you to invest even before these companies go public.
This opportunity has been constructing over the last few years. jeff brown tech stock 2021. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your spot totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers know that tech isn't our typical beat. And when it concerns tech investing, we leave it to the specialists. Luckily, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. brownstone research. He is among the most accomplished tech investing specialists we understand. In reality, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing exponential growth and developing incredible chances for investors. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now (united states). However regardless of what numerous readers may believe, this is a trend that's simply starting. Although the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months. Losing 2 months of manufacturing and sales truly impacts how many 5G devices are offered in the fiscal year. When you consider all of that, selling 250 million units is impressive (jeff brown biotech stock). More notably, the delays triggered by the pandemic developed a lots of pent-up need. Which need is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G devices will be delivered in 2021 - biotech stocks jeff brown. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually described its 3 various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase 3, 5G services start to be provided. That's when we begin to see applications operating on 5G networks. Think of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase 3 by this summertime. This begins something of a virtuous cycle: The majority of people do not truly care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone. bleeding edge.
That leads to more 5G apps being developed. In reality, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. jeff brown 2021 stock picks. All of these technologies require 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next essential technology I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology (tech predictions). At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For years, CRISPR was mostly a specific niche innovation that wasn't well understood. And during that time, there were really just 3 business running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This whole industry is successfully a greenfield opportunity.
There's room for numerous business to exist in this area. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the merging of biotech and expert system (AI) (exponential growth). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can properly predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is necessary since the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental procedure. first lady. Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug treatments produced utilizing this technology. This was one of those breakthroughs that almost no one discovered. But it's going to have extensive ramifications for curing disease. And, naturally, there will be plenty of financial investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021 - artificial intelligence. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back maybe substantially before going higher. I've been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake (the legacy report predictions). The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date since February 2021, but we might not individually confirm this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like capability to choose winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the market - korean actress. He's constantly on the hunt for new chances, and he shares numerous of his best choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully anticipated a few of the most significant financial events of the past 20 years. Although he doesn't appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking prowess. the legacy report predictions. Nobody on Wall Street gets it right whenever, however Jeff Brown's precise predictions have actually earned him legions of devoted followers. That states a lot about his ability. The Future Report is published by Brownstone Research, a prominent monetary research study publisher. Brownstone Research offers numerous research services with a variety of specializations.
The company is likewise associated with Bonner & Partners, another well-respected research publisher. On its website, Brownstone states its objective is to offer retail investors with professional-grade research: "For too long, the very best financial investment research has actually not been available to private financiers. It has been typically reserved for financial investment banks, hedge funds, personal equity, and high-net-worth clients. The objective of Brownstone Research is to make that kind of exclusive research study available to any financiers wanting to get an edge in the markets. The objective is simple to deliver special and rewarding financial investment research found nowhere else (jeff brown investment prediction)." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you know even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown believes S.A.V. might be "the most significant trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying 2 advanced technologies: artificial intelligence and electric vehicles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing short of the vehicle industry's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have been substantial this year, but the Wall Street device has actually been big on hype without much tangible result. Despite an extreme increase in competition over the past couple of years, Brown still believes Musk has the best possibility of putting it all together.
tech might be the magic string that connects it all together. S.A.V. means Shared Autonomous Automobile, and it might be the future of transport. Essentially, this technology would permit you to rent your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the vehicle and press a button on an app that informs the car to "sign up with the fleet (melania trump)." Next thing you know, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the profits. It sounds ridiculous, however it might be closed than you think.